As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.
6 Analysts have issued a Pharmasgp Holding forecast:
6 Analysts have issued a Pharmasgp Holding forecast:
Mar '25 |
+/-
%
|
||
Revenue | 92 92 |
14%
14%
|
|
Gross Profit | 83 83 |
15%
15%
|
|
EBITDA | 27 27 |
23%
23%
|
EBIT (Operating Income) EBIT | 20 20 |
22%
22%
|
Net Profit | 14 14 |
21%
21%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
PharmaSGP Holding SE engages in the manufacture of non-chemical, over-the-counter pharmaceutical products. Its product brands include RubaXX, Restaxil, FULMINAN, DESEO, Neradin, and TAUMEA. The company is headquartered in Gräfelfing, Germany.
Head office | Germany |
CEO | Peter Gerckens |
Employees | 89 |
Founded | 2012 |
Website | pharmasgp.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.